SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-001137
Filing Date
2024-02-14
Accepted
2024-02-14 13:49:51
Documents
11
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 20-F gmab-20231231x20f.htm 20-F 1323258
2 EX-8.1 gmab-20231231xex8d1.htm EX-8.1 4423
3 EX-12.1 gmab-20231231xex12d1.htm EX-12.1 9857
4 EX-12.2 gmab-20231231xex12d2.htm EX-12.2 9964
5 EX-13.1 gmab-20231231xex13d1.htm EX-13.1 6169
6 EX-13.2 gmab-20231231xex13d2.htm EX-13.2 6245
7 EX-15.1 gmab-20231231xex15d1.htm EX-15.1 3368
8 EX-97 gmab-20231231xex97.htm EX-97 16478
9 GRAPHIC gmab-20231231x20f001.jpg GRAPHIC 115716
10 GRAPHIC gmab-20231231x20f002.jpg GRAPHIC 84878
11 GRAPHIC gmab-20231231xex15d1002.jpg GRAPHIC 4410
  Complete submission text file 0001558370-24-001137.txt   1663423
Mailing Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
Business Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
GENMAB A/S (Filer) CIK: 0001434265 (see all company filings)

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 001-38976 | Film No.: 24635713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)